Pleiotrophin is a major regulator of the catecholamine biosynthesis pathway in mouse aorta

被引:21
作者
Ezquerra, L
Herradón, G
Nguyen, T
Vogt, TF
Bronson, R
Silos-Santiago, I
Deuel, TF
机构
[1] Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA
[2] Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA
[3] Millennium Pharmaceut Inc, Cambridge, MA 02139 USA
[4] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA
[5] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA
关键词
pleiotrophin; aorta; tyrosine hydroxylase; DOPA decarboxylase; dopamine beta-hydroxylase;
D O I
10.1016/j.bbrc.2004.08.121
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
To better understand the phenotype of pleiotrophin (PTN the protein, Ptn the gene) genetically deficient mice (Ptn-/-), we compared the transcriptional profiles of aortae obtained from Ptn-/- and wild type (WT, Ptn+/+) mice using a 14,400 gene microarray chip (Affymetrix) and confirmed the analysis of relevant genes by real time RT-PCR. We identified a dramatic upregulation of expression of tyrosine hydroxylase (TH), DOPA decarboxylase, and dopamine beta-hydroxylase in aortae of Ptn-/- mice in comparison with WT (Ptn +/+) mice. In contrast, transcripts of phenylethanolamine-N-methyltransferase, the enzyme catalyzing the conversion of norepinephrine into epinephrine, were not detected in aortae in either mouse strain. These findings suggest that Ptn gene expression has a critical role in determining the levels of expression of the enzymes of catecholamine biosynthesis in aorta and through this mechanism, PTN may regulate levels of endogenous catecholamine synthesis and potentially the vascular tone of aorta. (C) 2004 Elsevier Inc. All rights reserved.
引用
收藏
页码:512 / 517
页数:6
相关论文
共 49 条
[41]   Role of perivascular sympathetic nerves and regional differences in the features of sympathetic innervation of the vascular system [J].
Tsuru, H ;
Tanimitsu, N ;
Hirai, T .
JAPANESE JOURNAL OF PHARMACOLOGY, 2002, 88 (01) :9-13
[42]  
VANDERWINDEN JM, 1992, ANAT EMBRYOL, V186, P387
[43]   Induction of human osteoprogenitor chemotaxis, proliferation, differentiation, and bone formation by osteoblast stimulating factor-1/pleiotrophin: Osteoconductive biomimetic scaffolds for tissue engineering [J].
Yang, XB ;
Tare, RS ;
Partridge, KA ;
Roach, HI ;
Clarke, NM ;
Howdle, SM ;
Shakesheff, KM ;
Oreffo, RO .
JOURNAL OF BONE AND MINERAL RESEARCH, 2003, 18 (01) :47-57
[44]  
Yeh HJ, 1998, J NEUROSCI, V18, P3699
[45]  
YEH HJ, 2004, UNPUB PLEIOTROPHIN A
[46]  
Zhang N, 1999, Curr Opin Hematol, V6, P44, DOI 10.1097/00062752-199901000-00008
[47]   Human breast cancer growth inhibited in vivo by a dominant negative pleiotrophin mutant [J].
Zhang, N ;
Zhong, R ;
Wang, ZY ;
Deuel, TF .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (27) :16733-16736
[48]   Domain structure of pleiotrophin required for transformation [J].
Zhang, N ;
Zhong, R ;
Deuel, TF .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (19) :12959-12962
[49]  
ZHANG N, 2004, IN PRESS IDENTIFICAT